{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:04:00Z","timestamp":1784952240436,"version":"3.55.0"},"reference-count":78,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Obsessive-compulsive disorder (OCD) is a disabling illness that is associated with significant functional impairment. Although evidence-based pharmacotherapies exist, currently available medications are ineffective in some patients and may cause intolerable side effects in others. There is an urgent need for new treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>A growing body of basic and clinical research has showed that the endocannabinoid system (ECS) plays a role in anxiety, fear, and repetitive behaviors. At the same time, some patients with OCD who smoke cannabis anecdotally report that it relieves their symptoms and mitigates anxiety, and several case reports describe patients whose OCD symptoms improved after they were treated with cannabinoids. Taken together, these findings suggest that the ECS could be a potential target for novel medications for OCD. In this study, we review evidence from both animal and human studies that suggests that the ECS may play a role in OCD and related disorders. We also describe findings from studies in which cannabinoid drugs were shown to impact symptoms of these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>An emerging body of evidence suggests that the ECS plays a role in OCD symptoms and may be a target for the development of novel medications. Further exploration of this topic through well-designed human trials is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2018.0049","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:38:42Z","timestamp":1559223522000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":33,"title":["The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?"],"prefix":"10.1177","volume":"4","author":[{"given":"Reilly R.","family":"Kayser","sequence":"first","affiliation":[{"name":"Department of Psychiatry, New York State Psychiatric Institute, Columbia University Vagelos College of Physicians and Surgeons, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar","family":"Snorrason","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, New York State Psychiatric Institute, Columbia University Vagelos College of Physicians and Surgeons, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Haney","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, New York State Psychiatric Institute, Columbia University Vagelos College of Physicians and Surgeons, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Blair","family":"Simpson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, New York State Psychiatric Institute, Columbia University Vagelos College of Physicians and Surgeons, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,6,14]]},"reference":[{"key":"e_1_3_2_2_2","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","author":"Kessler RC","year":"2005","unstructured":"Kessler RC, , Berglund P, , Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_2_3_2","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th ed. Washington DC: American Psychiatric Association; 2015."},{"key":"e_1_3_2_4_2","unstructured":"Murray CJL Lopez AD. The global burden of disease: a comprehensive assessment of mortality and morbidity from disease injuries and risk factors in 1990 and projected to 2020. World Health Organization Harvard 1996."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/foc.5.3.foc299"},{"key":"e_1_3_2_6_2","first-page":"526","article-title":"A pharmaco-economic and quality of life study of obsessive compulsive disorder","volume":"31","author":"Hollander E","year":"1995","unstructured":"Hollander E, , Rowland C, , Stein DJ, et al. A pharmaco-economic and quality of life study of obsessive compulsive disorder. Psychopharmacol Bull. 1995; 31:526.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/da.22103"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001823"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv047"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-018-0246-8"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn4036"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.01.051"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.3\/ggoodwin"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.4.459"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70181-7"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000297870"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.12.005"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2011.11.003"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.04.043"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.04.013"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3811"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0387-1"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2008.00108.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.01.037"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.05.002"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.07.028"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2011.0381"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704327"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2015.10.002"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4867-07.2007"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.15"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2016.1145794"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2016.12.033"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2014.03.026"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-062111-150420"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.123"},{"key":"e_1_3_2_37_2","first-page":"6","article-title":"Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration","author":"H\u00e4ring M","year":"2011","unstructured":"H\u00e4ring M, , Kaiser N, , Monory K, et al. Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration. PLoS One. 2011; 6.","journal-title":"PLoS One"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2009.07.014"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.162"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature00839"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.04.023"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.08.035"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.06.063"},{"key":"e_1_3_2_44_2","first-page":"219","article-title":"Cannabidiol, a cannabis sativa constituent, as an anxiolytic drug","volume":"34","author":"de Mello Schier AR","year":"2012","unstructured":"de Mello Schier AR, , de Oliveira Ribeiro NP, , de Oliveira e Silva AC, et al. Cannabidiol, a cannabis sativa constituent, as an anxiolytic drug. Rev Bras Psiquiatr. 2012; 34:219\u2013232.","journal-title":"Rev Bras Psiquiatr"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.251"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7395"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.72"},{"key":"e_1_3_2_48_2","first-page":"588","article-title":"International union of basic and clinical pharmacology, LXXIX","volume":"62","author":"Pertwee RG","year":"2010","unstructured":"Pertwee RG, , Howlett AC, , Abood ME, et al. International union of basic and clinical pharmacology, LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev. 2010; 62:588\u2013631.","journal-title":"Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.11.027"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.12.030"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12051"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2415-0"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e32833b33c5"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2011.04.031"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000104"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2013.09.009"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.06.008"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2008.00071.x"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2014.11.002"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000180"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12944"},{"key":"e_1_3_2_62_2","unstructured":"National Academies of Sciences Engineering and Medicine. The health effects of cannabis and cannabinoids. National Academies Press Washington DC 2017."},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/294264"},{"key":"e_1_3_2_64_2","first-page":"CD006565","article-title":"Cannabinoids for Tourette's syndrome (review)","volume":"4","author":"Curtis A","year":"2009","unstructured":"Curtis A, , Clarke CE, , Rickards HE. Cannabinoids for Tourette's syndrome (review). Cochrane Database Syst Rev. 2009; 4:CD006565.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0376-4"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2347-8"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07061016"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.16030053"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.05.005"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2553"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13267"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2014.44"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0703472104"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.04.034"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2013.04.052"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2012.01815.x"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.07.051"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.258"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.07.029"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2018.0049","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2018.0049","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2018.0049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:10:49Z","timestamp":1777385449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2018.0049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6,1]]}},"alternative-id":["10.1089\/can.2018.0049"],"URL":"https:\/\/doi.org\/10.1089\/can.2018.0049","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}